findmyKOL

Michael Schieber

Basic profile

Northwestern Medicine Lake Forest Hospital

ORCIDNPI
RegionLake Forest, IL · MidwestSpecialtyHematology / OncologyFocusOncology
Active KOLEmergingfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Michael Schieber is an Oncology physician affiliated with Northwestern Medicine Lake Forest Hospital. OpenAlex indexes 56 publications with 9,303 citations (h-index 15).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
56publications

Distinct works indexed by OpenAlex, matched via ORCID.

9,303citations

Total citations across indexed works.

15h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
5companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1000 N Westmoreland Rd Ste 4
Lake Forest, IL 600451658

Telephone

847-582-2134

Provider last certified this registry record 26 Aug 2021.

View the NPPES registry record

Industry payments

5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Blood & clotting

    30.4%
    Factor Xa inhibitor27.1%
    Eliquis65%Xarelto35%
    Part D50 patients
    Low Molecular Weight Heparin2.1%
    Enoxaparin Sodium100%
    Part D<11 patients

    + 1 more class in this area

  • Cancer & immunology

    23.5%
    Kinase inhibitor5.1%
    Bosulif43%Jakafi35%Iclusig22%
    Part D<11 patients
    Antimetabolite4.8%
    Hydroxyurea100%
    Part D17 patients

    + 4 more classes in this area

  • Metabolism & gastrointestinal

    11.5%
    Corticosteroid5.2%
    Prednisone100%
    Part D21 patients
    Serotonin-3 Receptor Antagonist2.7%
    Ondansetron Odt62%Ondansetron Hcl38%
    Part D<11 patients

    + 2 more classes in this area

Where care is delivered (Part B)6% facility · 94% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”